Literature DB >> 7522257

Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.

D E Zhang1, C J Hetherington, D A Gonzalez, H M Chen, D G Tenen.   

Abstract

CD14, a monocyte/macrophage receptor for the complex of LPS and LPS binding protein, is a differentiation marker for the monocyte/macrophage lineage. We have analyzed the regulation of CD14 expression during 1 alpha,25-dihydroxyvitamin D3 (VitD3)-induced monocytic differentiation. Using FACS, Northern blotting, and nuclear run-on analyses, we demonstrate that the up-regulation of CD14 expression during monocytic cell maturation is regulated mainly at the level of gene transcription, and that new protein synthesis is required for CD14 induction. We have recently cloned the CD14 5' upstream sequence and demonstrated its tissue-specific promoter activity. Using stable transfection of the monocytoid U937 cell line with a series of deletion mutants of the CD14 5' upstream sequence coupled to a reporter gene construct, we show that bp -128 to -70 is the critical region for the induction of CD14 expression. This region contains two binding sites for the Sp1 transcription factor. A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression. Electrophoretic mobility shift analysis does not detect a direct interaction of the CD14 distal Sp1-binding site with the vitamin D3 receptor and its partner, the retinoid X receptor. These data demonstrate that VitD3 induces CD14 indirectly through some intermediary factor, and suggest a critical role for Sp1 in this process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522257

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Intermediate stages in monocyte-macrophage differentiation modulate phenotype and susceptibility to virus infection.

Authors:  K C McCullough; S Basta; S Knötig; H Gerber; R Schaffner; Y B Kim; A Saalmüller; A Summerfield
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

2.  Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis.

Authors:  A Spittler; M Willheim; F Leutmezer; R Ohler; W Krugluger; C Reissner; T Lucas; T Brodowicz; E Roth; G Boltz-Nitulescu
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target.

Authors:  A Etxabe; M C Lara-Castillo; J M Cornet-Masana; A Banús-Mulet; M Nomdedeu; M A Torrente; M Pratcorona; M Díaz-Beyá; J Esteve; R M Risueño
Journal:  Leukemia       Date:  2017-02-14       Impact factor: 11.528

4.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.

Authors:  D E Zhang; P Zhang; N D Wang; C J Hetherington; G J Darlington; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation.

Authors:  M Husmann; Y Dragneva; E Romahn; P Jehnichen
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

6.  Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation.

Authors:  S A Burel; N Harakawa; L Zhou; T Pabst; D G Tenen; D E Zhang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

7.  Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells.

Authors:  P J Ferret; E Soum; O Negre; E E Wollman; D Fradelizi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

8.  Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense.

Authors:  Sif Hansdottir; Martha M Monick; Sara L Hinde; Nina Lovan; Dwight C Look; Gary W Hunninghake
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  LPS-induced systemic inflammation is more severe in P2Y12 null mice.

Authors:  Elisabetta Liverani; Mario C Rico; Laxmikausthubha Yaratha; Alexander Y Tsygankov; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  J Leukoc Biol       Date:  2013-10-18       Impact factor: 4.962

10.  5-Lipoxygenase inhibitors potentiate 1alpha,25-dihydroxyvitamin D3-induced monocytic differentiation by activating p38 MAPK pathway.

Authors:  Lenka Stixová; Jirina Procházková; Karel Soucek; Jirina Hofmanová; Alois Kozubík
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.